Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

Predominance of AT1 Blockade Over Mas–Mediated Angiotensin-(1–7) Mechanisms in the Regulation of Blood Pressure and Renin–Angiotensin System in mRen2.Lewis Rats

(2013) Jasmina Varagic et al.   AMERICAN JOURNAL OF HYPERTENSION

Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy

(2013) Takashi Ono et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?

(2013) J. Wysocki et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria

(2012) Se Eun Park et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Possible Involvement of Angiotensin-Converting Enzyme 2 and Mas Activation in Inhibitory Effects of Angiotensin II Type 1 Receptor Blockade on Vascular Remodeling

(2012) Masaru Iwai et al.   HYPERTENSION

Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice

(2012) Mahmoud S. Alghamri et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

(2012) Renisha Nadarajah et al.   KIDNEY INTERNATIONAL

Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes

(2012) Fengxia Xiao et al.   PLoS One

Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition

(2011) Shinji Inaba et al.   JOURNAL OF HYPERTENSION

ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy

(2011) Amrisha Verma et al.   MOLECULAR THERAPY

Urinary angiotensin-converting enzyme 2 in patients with CKD

(2011) SONOO MIZUIRI et al.   NEPHROLOGY

Urocanic acid as an efficient hydroxyl radical scavenger: a quantum theoretical study

(2010) Saumya Tiwari et al.   JOURNAL OF MOLECULAR MODELING

Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects

(2010) Shin-ichiro Miura et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2

(2009) Jan Wysocki et al.   HYPERTENSION

Molecule-specific Effects of Angiotensin II-Receptor Blockers Independent of the Renin-Angiotensin System

(2008) T. W. Kurtz et al.   AMERICAN JOURNAL OF HYPERTENSION

Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

(2008) Julie R Ingelfinger   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

(2008) G. Wang et al.   DIABETOLOGIA